Global Reach

Positive Impact Across Borders

Our international locations, lightning pace of ideation, more than 50,000 products, presence in a majority of global research labs and status as the world’s largest supplier of tools for human identification testing and forensic DNA analysis ensure the resonance of our daily work.

Our commercial scale and unmatched investment in research and development deliver a unique breadth of opportunities for career development across miles, disciplines and depths of expertise. Our approximately 9,500 experts in 110 countries create change on an incomparable scale. When you work with us in any role, you transform life by enabling revolutionary developments in medicine, genetics, forensics, biofuels, business, science and beyond by supporting researchers and scientists around the world in the following areas:

  • Personalized Medicine
  • Regenerative Science
  • Molecular Diagnostics
  • Agricultural and Environmental Research
  • 21st-Century Forensics

We’re enabling scientific progress around the world – everywhere you are.

  • United States
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • China
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong
  • Italy
  • Japan
  • Korea
  • Mexico
  • Norway
  • Poland
  • Portugal
  • Russia
  • Singapore
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • The Netherlands
  • United Kingdom

News

  • TGen Study

    LifeTechnologies Corporation announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies. The goal of this first-of-its-kind research collaboration is to demonstrate whether genomic sequencing of cancer tissue can provide clues for treatment strategies for these individuals.

    Read All Close
  • SMS Technology

    Life Technologies Corporation announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.

    Read All Close
  • SOLiD PI ANNOUNCED

    Life Technologies Corporation today announced plans for the Applied Biosystems SOLiD(TM) PI System, a new highly accurate, flexible and easy-to-use genomic analysis platform that will bring next-generation sequencing within the grasp of all life science research laboratories worldwide. Early customer adoption of the SOLiD PI System is expected to begin in the second half of 2010.

    Read All Close

Life (Common Stock)